Eliciting the public preferences for pharmaceutical subsidy in Iran: a discrete choice experiment study.

ABSTRACT:

Background

Deciding on pharmaceutical subsidy is regarded as a challenging issue for healthcare policymakers in Iran in most times. Public preferences, rarely attended in Iran, could be invaluable for including a particular drug in the list of subsidized medications.

Objectives

The current study aims to elicit the public preferences to develop an evidence-based decision-making framework for entering a drug into the list of subsidies in Iran.

Methods

Discrete Choice Experiment (DCE) was employed to elicit the public preferences. Around 34 attributes were identified based on the systematic review and interview with 51 experts. By holding an expert panel, 7 attributes were finalized, namely: the survival after treatment, quality of life after treatment (QoL), alternative

SUBMITTER: Delpasand M 

PROVIDER: S-EPMC8278681 | biostudies-literature | 2021 Jul

REPOSITORIES: biostudies-literature